OBALON THERAPEUTICS INC·4

Jul 25, 4:30 PM ET

Plovanic William J. 4

4 · OBALON THERAPEUTICS INC · Filed Jul 25, 2019

Insider Transaction Report

Form 4
Period: 2019-07-23
Plovanic William J.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-07-23+300,000300,000 total
    Exercise: $0.96Exp: 2029-07-23Common Stock (300,000 underlying)
Footnotes (2)
  • [F1]The option shall vest as to 1/48th of the shares underlying the option on each monthly anniversary of May 20, 2019, subject to Mr. Plovanic's continued status as a service provider with the Issuer through the applicable vesting date.
  • [F2]Share amounts do not reflect the impact of a 1-for-10 reverse stock split that became effective after the grant date for the options referenced herein.

Documents

1 file
  • 4
    marketforms-45370.xmlPrimary

    PRIMARY DOCUMENT